A comparative analysis demonstrated significantly higher expression levels of N-cadherin, CD44, and vimentin in patients with GBM with high CYBB expression, suggesting the remarkable expression of CYBB in mesenchymal GBM cells (Figure 2B). The gene discussed is CD44; the disease is glioblastoma.